Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase

被引:111
作者
Jang, Kyoung Jin [2 ]
Lee, Na-Ra [1 ]
Yeo, Woon-Seok [3 ]
Jeong, Yong-Joo [1 ]
Kim, Dong-Eun [3 ]
机构
[1] Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea
[2] Dong Eui Univ, Dept Biomat Control, Pusan 614714, South Korea
[3] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea
基金
新加坡国家研究基金会;
关键词
SARS coronavirus; nsP10; NTPase/Helicase; RNA aptamer SELEX;
D O I
10.1016/j.bbrc.2007.12.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent outbreak of Severe Acute Respiratory Syndrome (SARS) that caused almost 800 victims requires a development of efficient inhibitor against SARS coronavirus (SCV). In this study, RNA aptamers against SCV NTPase/Helicase (nsP10) were isolated from RNA library containing random sequences of 40 nts using in vitro selection technique. Nucleotide sequences of enriched RNA aptamer pool (ES15 RNA) contain AG-rich conserved sequence of 10-11 nucleotides [AAAGGR(G)GAAG; R, purine base] and/or additional sequence of 5 nucleotides [GAAAG], which mainly reside at the loop region in all the predicted secondary structures. Isolated RNAs were observed to efficiently inhibit double-stranded DNA unwinding activity of the helicase by up to similar to 85% with an IC50 value of 1.2 nM but show a slight effect on ATPase activity of the protein in the presence of cofactor, poly (rU). These results suggest that the pool of selected aptamers might be potentially useful as anti-SCV agents. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:738 / 744
页数:7
相关论文
共 24 条
[1]   Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs [J].
Anand, K ;
Ziebuhr, J ;
Wadhwani, P ;
Mesters, JR ;
Hilgenfeld, R .
SCIENCE, 2003, 300 (5626) :1763-1767
[2]   Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro [J].
Bacha, U ;
Barrila, J ;
Velazquez-Campoy, A ;
Leavitt, SA ;
Freire, E .
BIOCHEMISTRY, 2004, 43 (17) :4906-4912
[3]   Tertiary structure prediction of SARS coronavirus helicase [J].
Bernini, A ;
Spiga, O ;
Venditti, V ;
Prischi, F ;
Bracci, L ;
Huang, JD ;
Tanner, JA ;
Niccolai, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (04) :1101-1104
[4]   Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase [J].
Biroccio, A ;
Hamm, J ;
Incitti, I ;
De Francesco, R ;
Tomei, L .
JOURNAL OF VIROLOGY, 2002, 76 (08) :3688-3696
[5]   Direct fluorometric measurement of hepatitis C virus helicase activity [J].
Boguszewska-Chachulska, AM ;
Krawczyk, M ;
Stankiewicz, A ;
Gozdek, A ;
Haenni, AL ;
Strokovskaya, L .
FEBS LETTERS, 2004, 567 (2-3) :253-258
[6]   Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy [J].
Borowski, P ;
Schalinski, S ;
Schmitz, H .
ANTIVIRAL RESEARCH, 2002, 55 (03) :397-412
[7]   Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease [J].
Crute, JJ ;
Grygon, CA ;
Hargrave, KD ;
Simoneau, B ;
Faucher, AM ;
Bolger, G ;
Kibler, P ;
Liuzzi, M ;
Cordingley, MG .
NATURE MEDICINE, 2002, 8 (04) :386-391
[8]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[9]   Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease [J].
Fukuda, K ;
Vishnuvardhan, D ;
Sekiya, S ;
Hwang, J ;
Kakiuchi, N ;
Kazunari, T ;
Shimotohno, K ;
Kumar, PKR ;
Nishikawa, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (12) :3685-3694
[10]   Isolation of specific against NS3 helicase and high-affinity RNA aptamers domain of hepatitis C virus [J].
Hwang, B ;
Cho, JS ;
Yeo, HJ ;
Kim, JH ;
Chung, KM ;
Han, K ;
Jang, SK ;
Lee, SW .
RNA, 2004, 10 (08) :1277-1290